Imagine a world where the aerospace and medical industries can produce critical components at a fraction of the current cost, without compromising on strength or reliability. This vision is inching closer to reality thanks to a groundbreaking development by engineers at RMIT University in
In the intricate world of pharmaceutical regulation, a lingering debate continues to challenge industry standards and scientific rationale, particularly around the mandatory testing for alkyl sulfonate ester contaminants in sulfonate-salt drugs across Europe and the UK. These compounds, flagged as
Nigeria stands at a critical crossroads as it battles a severe food crisis characterized by skyrocketing prices and pervasive hunger that threatens the well-being of millions across the nation. The Federal Government’s recent decision to grant import licenses for grains such as rice has emerged as
Imagine a world where a single 3D printing file format can seamlessly bridge the gap between design and production, eliminating errors and ensuring consistency across diverse technologies and industries. This is no longer a distant dream but a reality with the 3D Manufacturing Format (3MF), a
In an era where the aerospace industry faces constant pressure to innovate and reduce environmental impact, a significant development has emerged from one of the sector’s key players. Safran, a leading aerospace company, has taken a bold step forward by expanding its additive manufacturing
In a striking reaction to President Donald Trump’s aggressive tariff threats designed to ramp up domestic production, pharmaceutical powerhouses are channeling billions into expanding manufacturing within the United States, signaling a major shift in response to political pressure. Industry leaders
